Back to search
FDAFDA · Food and drugs·Recall number D-0743-2026

Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1

Published August 12, 2026 · Recall initiated: July 17, 2026

Summary

FDA records drug Class I recall D-0743-2026, published August 12, 2026 and initiated July 17, 2026. Recalling firm: Sunny Pharmtech Inc.; Status: Ongoing; Reported quantity: 4,077 vials; Lot: Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; identified as stainless steel

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sunny Pharmtech Inc.
Distributor
USA Nationwide
Lot
Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/2027
Risk classification
Class I
Area (FDA)
drug
Country
Taiwan

Related recalls

Questions about this recall

Was Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1 recalled?

Yes. FDA published recall D-0743-2026 on August 12, 2026. Reported hazard: Presence of Particulate Matter; identified as stainless steel

What should I do if I have this product?

Voluntary: Firm initiated · Letter